The pyridoxal-5′-phosphate-dependent catalytic antibody 15A9: its efficiency and stereospecificity in catalysing the exchange of the α-protons of glycine  by Mahon, Marrita M. et al.
The pyridoxal-5P-phosphate-dependent catalytic antibody 15A9:
its e⁄ciency and stereospeci¢city in catalysing the exchange
of the K-protons of glycine
Marrita M. Mahona, Svetlana I. Gramatikova1;b, Philipp Christenb, Teresa B. Fitzpatricka,
J. Paul G. Malthousea;*
aDepartment of Biochemistry, University College Dublin, Bel¢eld, Dublin 4, Ireland
bBiochemisches Institut der Universitaºt Zuºrich, Zuºrich, Switzerland
Received 23 March 1998
Abstract 13C-NMR has been used to follow the exchange of
the K-protons of [2-13C]glycine in the presence of pyridoxal-5P-
phosphate and the catalytic antibody 15A9. In the presence of
antibody 15A9 the 1st order exchange rates for the rapidly
exchanged proton of [2-13C]glycine were only 25 and 150 times
slower than those observed with tryptophan synthase (EC
4.2.1.20) and serine hydroxymethyltransferase (EC 2.1.2.1).
The catalytic antibody increases the 1st order exchange rates of
the K-protons of [2-13C]glycine by at least three orders of
magnitude. We propose that this increase is largely due to an
entropic mechanism which results from binding the glycine-
pyridoxal-5P-phosphate Schiff base. The 1st and 2nd order
exchange rates of the pro-2S proton have been determined but we
were only able to determine the 2nd order exchange rate for the
pro-2R proton of glycine. In the presence of 50 mM glycine the
antibody preferentially catalyses the exchange of the pro-2S
proton of glycine. The stereospecificity of the 2nd order
exchange reaction was quantified and we discuss mechanisms
which could account for the observed stereospecificity.
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1. Introduction
A wide range of catalytic antibodies have been produced
which catalyse a diverse range of reactions with varying de-
grees of catalytic e⁄ciency [1^3]. Most catalytic antibodies are
formed by producing antibodies which bind transition state
analogues. This approach is made more di⁄cult when at-
tempting to mimic enzymes which utilise cofactors. One of
the earliest attempts at generating catalytic antibodies which
bound a cofactor was reported by Raso and Stollar who gen-
erated polyclonal antibodies to a reduced aldimine hapten
formed from 3-aminotyrosine and pyridoxal-5P-phosphate
[4^6]. The antibodies formed bound the hapten but did not
have any signi¢cant catalytic properties. A similar approach
has been used to generate a monoclonal antibody which cat-
alyses Schi¡ base formation between D-p-nitrophenylalanine
and 5P-deoxypyridoxal [7]. This procedure has also been
used to produce a monoclonal antibody, the catalytic anti-
body 15A9, which will catalyse in addition to Schi¡ base for-
mation, transamination and K-, L-elimination reactions [8,9].
It is this antibody that we have studied in the present work.
Pyridoxal-5P-phosphate-dependent enzymes catalyse a wide
range of reactions in amino acid metabolism [10^12]. The
pyridoxal-5P-phosphate cofactor is capable of catalysing a
range of reactions involving amino acids and one of the
main roles of the protein component of these enzymes is to
direct catalysis down one of the many potential reaction path-
ways [12]. Dunathan has proposed that the course of the re-
action will be determined by which of bonds from the K-car-
bon to the K-carboxylate, the K-proton or the R-group lies
together with the imine nitrogen atom in a plane orthogonal
to the plane of the imine-cofactor p-electron system [13]. The
majority of the reactions catalysed by pyridoxal-5P-phosphate-
dependent enzymes proceed via loss of the K-proton of the
amino acid substrate making this a key step in catalysis [11].
The stereospeci¢city of the exchange of the K-protons of L-
and D-amino acids or of glycine is expected to depend on
which of the K-protons is orthogonal to the plane of the
imine-cofactor p-electron system [14,15]. Recent NMR kinetic
studies have quanti¢ed the stereospeci¢city of the tryptophan
synthase and serine hydroxymethyltransferase catalysed ex-
change of the K-protons of glycine [16^21]. In the present
work we use the same approach to determine and quantify
the stereospeci¢city of the exchange of the K-protons of
glycine when it is catalysed by the catalytic antibody 15A9.
We compare our results with those obtained with tryptophan
synthase, serine hydroxymethyltransferase and model com-
pounds.
2. Materials and methods
2.1. Materials
[2-13C]glycine (99 atom %), 2H2O (99.8 atom %) and 1,3-bis[tris-
(hydroxymethyl)methylamino]-propane were obtained from Aldrich
Chemical Co. and Fluka Chemicals Ltd. respectively at Gillingham,
Dorset, UK. All other chemicals used were obtained from Sigma
Chemical Co., Poole, Dorset, UK.
2.2. Catalytic activity of the catalytic antibody 15A9
All measurements were performed in 0.05 M 1,3-bis[tris(hydroxy-
methyl)methylamino]propane, 0.14 M NaCl, pH 7.0. The production
of pyruvate from L-chloro-D-alanine (5^65 mM), in the presence of 1^
5 WM antibody and 1 mM pyridoxal-5P-phosphate, was measured in a
coupled assay with lactate dehydrogenase and NADH. The concen-
tration of antibody protein was determined using E280mg=ml = 1.4 [8]
and Mr = 150 000. The concentrations of antibody binding sites were
calculated using kcat = 50 min31 for L-chloro-D-alanine [9] and by
assuming that there were 2 moles of binding sites per mole of protein.
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2.3. Determination of the apparent dissociation constant of the
glycine-pyridoxal-5P-phosphate Schi¡ base
10^50 Wl aliquots of 0.1^1.0 M glycine were added to 0.7 ml of 50
WM pyridoxal-5P-phosphate in 0.05 M potassium phosphate, pH 7.0
to give solutions containing 1.4^71.4 mM glycine. The absorbance at
440 nm was measured after each addition of glycine. The apparent
dissociation constant was determined by ¢tting the experimental data
to the following equation,vA440obs  vA440maxWK=S  K:
2.4. Preparation of [2-13C,pro-2S-2H]glycine
All solutions were prepared in 99.9 atom % 2H2O. The serine hy-
droxymethyltransferase catalysed exchange of the pro-2S proton of [2-
13C]glycine was initiated by adding 0.05 ml of 1.46 mM serine hydrox-
ymethyltransferase to a 2.45 ml solution containing 76 mg [2-
13C]glycine and 0.05 M potassium phosphate at pH 7.0. The solution
of 2.5 ml contained 29.2 WM serine hydroxymethyltransferase and 0.4
M [2-13C]glycine. When the exchange of the pro-2S proton was com-
pleted, the reaction was stopped by the addition of 0.5 ml of 1 M
deuterium chloride to the sample. The pH was restored to 7.0 with the
addition of 0.24 ml of [2H]potassium hydroxide. The precipitated
enzyme was removed by centrifugation and the remaining solution
assayed for serine hydroxymethyltransferase activity. No residual en-
zyme activity could be detected. The sample was then freeze-dried and
dissolved in 1.0 ml 2H2O to give a solution containing 0.97 M [2-
13C,pro-2S-2H]glycine, 0.07 M KCl and 0.12 M potassium phosphate
at pH 7.0.
2.5. NMR spectra
Spectra were recorded using a Bruker WP80 wide bore spectrometer
operating at 20.115 mHz for 13C-nuclei. Sample sizes were 0.9^1.0 ml
with 10 mm diameter sample tubes. Spectral conditions were: 8000
time domain data points; 0.852 s acquisition time; spectral width 240
p.p.m.; 2 Hz exponential weighting factor; 11‡ pulse. Proton decou-
pling was not used.
2.6. NMR samples: determining the stereospeci¢city of exchange
All samples were made up in 99.8 or 99.9 atom % 2H2O and con-
tained 0.05 M 1,3-bis[tris(hydroxymethyl)methylamino]propane, 0.14
M NaCl, pH 7.1.
Antibody 15A9 catalysed exchange of the K-protons of [2-
13C]glycine were initiated by adding 0.045 ml of 1.0 M [2-13C]glycine
to an 0.855 ml solution containing antibody 15A9. The ¢nal solution
of 0.9 ml contained 26.7 WM antibody binding sites, 1 mM pyridoxal-
5P-phosphate and 0.05 M [2-13C]glycine.
All NMR spectra were recorded at 25 þ 1‡C. However, one sample
(Fig. 1b^d) was maintained at 37‡C in between recording NMR spec-
tra by storing the NMR tube containing the sample in a water bath
¢lled with distilled water at 37‡C. The other sample (Fig. 1a, e^g) was
kept at 25 þ 1‡C until our studies were completed. pH values were
recorded at the end of the reactions with an electrode standardised
in 1H2O bu¡ers before being transferred to 2H2O.
The stereospeci¢city of the antibody 15A9 catalysed exchange of
the K-protons of glycine was determined by adding tryptophan syn-
thase to the sample incubated with the catalytic antibody at 25 þ 1‡C
and serine hydroxymethyltransferase to the sample incubated with the
catalytic antibody at 37‡C. Fifteen WM tryptophan synthase and 1.4
WM serine hydroxymethyltransferase were incorporated into the ap-
propriate samples. When adding serine hydroxymethyltransferase full
anaerobic precautions were taken and 5 mM 2-mercaptoethanol and
0.2 mM tetrahydrofolic acid were incorporated into the sample [16].
2.7. NMR samples: antibody 15A9 catalysed exchange of the pro-2S
proton of [2-13C]glycine
All samples were prepared in 99.8 atom % 2H2O containing 0.05 M
1,3-bis[tris(hydroxymethyl)methylamino]propane, 0.14 M NaCl, pH
7.1. Exchange of the pro-2S proton of [2-13C]glycine was initiated
by adding 0.045^0.36 ml of 1 M [2-13C]glycine to solutions containing
0.018^0.037 ml antibody. The ¢nal 0.9 ml samples contained 1 mM
pyridoxal-5P-phosphate, 0.16^0.30 WM antibody binding sites and
0.05^0.4 M [2-13C]glycine. The exchange was followed by initial rate
measurements [19].
2.8. Antibody 15A9 catalysed exchange of the pro-2R proton of
[2-13C,pro-2S-2H]glycine
All samples were prepared in 99.9 atom % 2H2O containing 0.05 M
1,3-bis[tris(hydroxymethyl)methylamino]propane bu¡er and 0.14 M
NaCl at pH 7.1. Exchange of the pro-2R proton of [2-13C,pro-2S-
2H]glycine was initiated by the addition of 0.047^0.37 ml of [2-
13C,pro-2S-2H]glycine to solutions containing 0.19^0.49 ml antibody.
Bu¡er and pyridoxal-5P-phosphate were added to give ¢nal solutions
of 0.9 ml containing 1 mM pyridoxal-5P-phosphate, 3.4^9 WM anti-
body binding sites and 0.05^0.4 M [2-13C,pro-2S-2H]glycine. The ex-
change was followed by initial rate measurements [19]. In control
samples in which the antibody was omitted, no exchange of the
pro-2R of [2-13C,pro-2S-2H]glycine was detected.
3. Results and discussion
3.1. Exchange reactions catalysed by model compounds
Spectrophotometric studies showed that glycine and pyri-
doxal-5P-phosphate formed a Schi¡ base (Vmax = 410 nm)
which had an apparent dissociation constant of 9.4 þ 1.8
mM at pH 7.0 and 25‡C. However, the absorbance due to
the Schi¡ base decreased slowly with time. With 0.1 mM
pyridoxal-5P-phosphate and 0.4 M glycine the half life for
the breakdown of the Schi¡ base was 13.9 days at pH 7.0
and 25‡C. When this experiment was repeated using [2-
13C]glycine no evidence for the exchange of the K-protons of
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Fig. 1. Determination of the stereospeci¢city of antibody 15A9 cata-
lysed exchange of K-protons of [2-13C]glycine at pH 7.1. All samples
contained: 0.05 M [2-13C]glycine, 1 mM pyridoxal phosphate, 0.14
M sodium chloride, 0.05 M 1,3-bis[tris(hydroxymethyl)methylami-
no]propane at pH 7.1. The samples used for spectra b and c also
contained 26.7 WM catalytic antibody and were incubated at 37‡C
for 10.8 and 30.2 days respectively before spectrum acquisition be-
gan. Spectrum d was recorded under anaerobic conditions 2 h after
incorporating 1.4 WM serine hydroxymethyltransferase, 0.2 mM tet-
rahydrofolic acid and 5 mM 2-mercaptoethanol into the sample c.
Spectrum e was acquired 31.7 days after incubation with 26.7 WM
catalytic antibody at 25‡C. Spectra f and g were recorded 2 h after
the addition of 15 WM tryptophan synthase to the sample used for
spectrum e. 61440 transients were recorded for spectrum g while
16384 transients were recorded for spectra a^f. Acquisition parame-
ters were as described in Section 2.
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[2-13C]glycine was obtained. Therefore, we conclude that the
rate of exchange of the K-protons of [2-13C]glycine must be
much slower than the rate of breakdown of the Schi¡ base. By
examining the NMR spectra obtained over a period of one
half life for the breakdown of the Schi¡ base we estimate that
the exchange rate of the K-protons of 0.4 M [2-13C]glycine in
the presence of 0.1 mM pyridoxal-5P-phosphate must be
6 0.000002 s31. Increasing the concentration of pyridoxal-
5P-phosphate to 10 mM enabled us to observe the signal at
55.6 ppm due to the 13C-enriched carbon of the Schi¡ base
[22]. As expected, the rate of loss of the signal at 55.6 ppm
was the same as the rate at which the absorbance due to the
Schi¡ base at 410 nm decreased.
3.2. Determination of the stereospeci¢city of antibody 15A9
towards the K-protons of a glycine-pyridoxal-5P-phosphate
Schi¡ base
In the absence of proton decoupling the 13C-enriched K-
carbon of a control sample of [2-13C]glycine gives a character-
istic triplet (Fig. 1a). This control sample does not contain the
antibody but it does contain the same concentration of pyr-
idoxal-5P-phosphate as the samples of catalytic antibody. Re-
placement of one of the K-protons of glycine with a deuteron
results in a spectrum consisting of a pair of triplets (Fig. 1c^e)
while replacement of both protons with deuterons gives a
characteristic quintet (Fig. 1f, g). Therefore, we can use these
spectra to follow the exchange of the K-protons of glycine. We
obtained no evidence for any exchange of the K-protons of
glycine in the control sample over the duration of our experi-
ments. In the presence of the antibody there was V64% ex-
change of one of the K-protons after incubation at 37‡C for 11
days (Fig. 1b). The half life of exchange under these condi-
tions was V9 days and after 30 days at 37‡C there was
V84% exchange of one of the K-protons of [2-13C]glycine
(Fig. 1c). The sample was then made anaerobic and 1.4 WM
serine hydroxymethyltransferase in the presence of 0.2 mM
tetrahydrofolate was added. Under these conditions, serine
hydroxymethyltransferase will catalyse the exchange of the
pro-2S proton of glycine with a half life of V45 min [21]. If
the catalytic antibody catalysed the exchange of the pro-2R
proton, we expect it to have catalysed the exchange of more
than 75% of the remaining pro-2S protons after 2 h. However,
the addition of serine hydroxymethyltransferase did not cause
a detectable decrease in the intensity of the pair of triplets due
to the glycine which had one of its protons exchanged after 2 h
(Fig. 1d). This result suggests that the catalytic antibody has
preferentially catalysed the exchange of the pro-2S proton of
glycine. The unexchanged proton should be the pro-2R pro-
ton of glycine which should be preferentially exchanged by
tryptophan synthase [16]. After incubating the catalytic anti-
body with [2-13C]glycine for 32 days at 25‡C there was 86%
exchange of one of the K-protons of glycine (Fig. 1e). Under
these experimental conditions we calculate that 15 WM tryp-
tophan synthase will preferentially catalyse the exchange of
the pro-2R proton of glycine with a half life of V48 min
[19]. On adding 15 WM tryptophan synthase there was rapid
exchange of the non-exchanged proton to give a characteristic
quintet due to [2-13C,2H2]glycine (Fig. 1f, g). This result con-
¢rms that catalytic antibody 15A9 in the presence of pyridox-
al-5P-phosphate preferentially catalyses the exchange of the
pro-2S proton of glycine. The accumulation of the transients
of spectra f and g in Fig. 1 were both begun 2 h after adding
tryptophan synthase. The only di¡erence between these spec-
tra is that spectra f and g resulted from the accumulation of
16384 and 61440 transients respectively.
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Fig. 2. E¡ect of the concentration of [2-13C]glycine on the hydro-
gen-deuterium exchange rate of the pro-2S proton of [2-13C]glycine
catalysed by catalytic antibody 15A9 at pH 7.1. [2-13C]glycine con-
centrations of 0.05^0.4 M and antibody concentrations of 0.158^
0.314 WM were used. All samples contained 1 mM pyridoxal phos-
phate, 0.05 M 1,3-bis[tris(hydroxymethyl)methylamino]propane and
0.14 M NaCl at pH 7.1. The continuous line was calculated using
d[P]/[Ab]/dt = kaW[So]/([So]+K) and the ¢tted parameters ka = 0.067 þ
0.004 s31, K = 0.128 þ 0.017 M and ka/K = 0.523 þ 0.076 M31 s31.
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Pyridoxal-5P-phosphate 7.0 n.d. 90.000002 n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d.
15A9 antibody 7.1 pro-2S 0.067 0.13 0.52 pro-2R s 0.0076 s 0.4 0.019 6 9 28
K2L2-tryptophan
synthasea
7.0 pro-2R 1.7 0.054 32.0 pro-2S 0.0069 0.130 0.053 250 600
Serine hydroxy-
methyltransferaseb
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3.3. The e¡ect of glycine concentration on the exchange rates
of the K-protons of glycine by catalytic antibody 15A9
The exchange rates of the rapidly exchanged pro-2S protons
of [2-13C]glycine showed saturation kinetics (Fig. 2) which
allowed us to determine an apparent binding constant (K)
as well as the 1st and 2nd order exchange rates. However,
the exchange rates of the slowly exchanged pro-2R protons
of [2-13C]glycine were directly proportional to the concentra-
tion of [2-13C]glycine (Fig. 3) and so while we could measure
the 2nd order exchange rate we could only put limits on the
values of the apparent binding constant and 1st order ex-
change rate for the slowly exchanged pro-2R proton (Table
1).
3.4. Comparison of the exchange rates and stereospeci¢cities
obtained with catalytic antibody 15A9 and those obtained
with tryptophan synthase, serine hydroxymethyltransferase
and model compounds
For antibody 15A9 the 1st order exchange rates for the
rapidly exchanged proton of [2-13C]glycine were only 25 and
150 times slower than those observed with tryptophan syn-
thase and serine hydroxymethyltransferase (Table 1). How-
ever, the 1st order exchange rates of the slowly exchanged
protons of the 15A9 antibody were similar or greater than
those of tryptophan synthase and serine hydroxymethyltrans-
ferase (Table 1). Therefore, the greater stereospeci¢city of the
1st order exchange rates of the rapidly exchanged protons
with these enzymes is due to their ability to enhance the ex-
change rate of the rapidly exchanged protons and to reduce
the exchange rates of the slowly exchanged protons. For the
2nd order exchange rates, the exchange rates of the slowly
exchanged protons are similar (Table 1) and so speci¢city is
largely determined by the exchange rates of the rapidly ex-
changed protons.
The greater stereospeci¢city of the enzymes is largely due to
their greater e⁄ciency in catalysing the exchange of the rap-
idly exchanged protons (Table 1). For the enzymes it is ex-
pected that evolution will have resulted in them having acid-
base catalysts capable of catalysing the exchange of the rap-
idly exchanged proton. In tryptophan synthase the active site
lysine residue is thought to be the catalytic base [23] while in
serine hydroxymethyltransferase some other group is thought
to be the catalytic base [24]. But, no such selection process is
expected to occur when the catalytic antibody was produced
and so it is not surprising that its stereospeci¢city is V20^
100-fold less than that of the enzymes. However, this does not
explain why the catalytic antibody preferentially catalyses the
exchange of the pro-2S proton. It has been argued that for
optimal catalytic e⁄ciency, the K-carbon bond to be cleaved
should be orthogonal to the plane of the imine-cofactor Z-
electron system [13,15,19]. The stereospeci¢city of the anti-
body could be explained if the glycine-pyridoxal-5P-phosphate
Schi¡ base is bound such that the pro-2S proton of glycine is
closer than the pro-2R proton to this optimal position. Alter-
natively, the antibody could posses a base which preferentially
catalyses the exchange of the pro-2S proton. If exchange is
catalysed by a base on the antibody then we would expect the
rapidly exchanged pro-2S proton to point towards the pro-
tein. However, if exchange is not catalysed by a base on the
antibody then we would expect that the rapidly exchanged
pro-2S proton would point towards the solvent while the
slowly exchanged pro-2R proton would point towards the
protein and so be partially shielded from solvent. It has
been argued that pyridoxal-5P-phosphate-dependent enzymes
evolved from a common ancestor where the pyridoxal-5P-
phosphate adopts an extended conformation with the CK-H
bond orthogonal to the plane of the imine-cofactor ring and
pointing toward the surface of the protein to allow protein-
assisted deprotonation at CK [25]. Due to the low stereospe-
ci¢city of the 15A9 antibody we would not like to speculate as
to whether the rapidly exchanged pro-2S proton of glycine
points towards or away from the protein surface.
The catalytic antibody catalyses the exchange of the pro-2S
and pro-2R protons of glycine at a rate which is 34000- and
s 3800-fold faster than the corresponding model compound
(Table 1). As we have discussed, the rapidly exchanged proton
could be the one exposed to solvent or it could be pointing
towards the protein and its exchange catalysed by a protein
base. These mechanisms could explain why the 15A9 antibody
catalyses the exchange of the pro-2S proton more rapidly than
the pro-2R proton. However, they do not explain why the
slowly exchanged pro-2R proton of the glycine-pyridoxal-5P-
phosphate Schi¡ base is exchanged at least 3800 times faster
in the presence of the catalytic antibody than in its absence. It
has been shown that the loss of rotational energies on binding
can lead to large rate enhancements [26] and it has also been
suggested that the binding of NADH by lactate dehydrogen-
ase could promote catalysis by altering the distribution of
conformations in the cofactor [27]. Likewise, we suggest that
binding of the glycine-pyridoxal-5P-phosphate Schi¡ base by
the catalytic antibody should stop rotation about the bonds
formed between the K-amino group and the K-carbon of the
glycine moiety as well as the C-4 to C-4P bond of the cofactor.
This binding could optimise exchange by ensuring that the
imine-cofactor Z-electron system is planar and that the K-pro-
tons are perpendicular or nearly perpendicular to the plane of
the imine-cofactor Z-electron system. We propose that this
entropic mechanism could explain how the 15A9 antibody
catalyses the exchange of the pro-2R and pro-2S protons of
glycine.
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Fig. 3. E¡ect of the concentration of [2-13C,pro-2S-2H]glycine on
the hydrogen-deuterium exchange rate of the pro-2R proton of [2-
13C,pro-2S-2H]glycine catalysed by catalytic antibody 15A9 at pH
7.1. [2-13C,pro-2S-2H]glycine concentrations of 0.05^0.4 M and anti-
body concentrations of 3.4^9 WM were used. All samples contained
1 mM pyridoxal phosphate, 0.05 M 1,3-bis[tris(hydroxymethyl)meth-
ylamino]propane and 0.14 M NaCl at pH 7.1. The continuous line
was calculated using d[P]/[Ab]/dt = (ka/K)W[So] and the ¢tted parame-
ter ka/K = 0.019 þ 0.001 M31 s31.
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